Introducing MOVOFLEX® Soft Chews, the next generation in joint health supplementation
Virbac is pleased to announce the launch of new, innovative MOVOFLEX® Soft Chews, the next generation in joint care supplementation for dogs.
Virbac Charity Fundraiser at London Vet Show Proves Huge Success
Virbac is delighted to report the huge success of their innovative charity fundraising event that took place at last year’s London Vet Show (LVS 2022).
Suprelorin® Now Offers an Alternative to Surgical Castration in Cats
Virbac is pleased to announce that Suprelorin® 4.7mg Implants for Dogs, the innovative reversible alternative to surgical castration is now also licensed for use in male cats.
Missing Tilly is reunited with her owner after 17 years, thanks to her Microchip!
A missing cat, Tilly, has been reunited with her owner after 17 years! The remarkable reunion was only made possible because her vet nurse owner Kim had made sure Tilly was microchipped and then updated her microchip details each time she moved house during Tilly’s absence.
Helping Your Practice Cope with the Post-Pandemic Puppy Boom
With pressure on veterinary services higher than ever and an expanding population of pets with owners desiring alternatives to surgical castration, Virbac are pleased to offer Suprelorin®.
Vet Aquadent® FR3SH™ Now Includes Innovative FR3SH™ Technology
Virbac is pleased to announce that Vet Aquadent® FR3SH™, the palatable solution used in daily drinking water to reduce plaque build-up in cats and dogs, has a new and improved formulation which now contains the innovative FR3SH™ technology already found in the popular VeggieDent® FR3SH™ & ZEN™ Dental Chews.
The Use of Ciclosporin and HCA in Atopic Dermatitis and Otitis Externa
A 5-year-old, male, neutered, Maltese x Shih Tsu dog presented with intermittent, recurrent and chronic otitis externa; he has had since 4 months of age with the left ear being worse than the right.
The Use of Ciclosporin and HCA and Canine Atopic Dermatitis
A 7-month-old, female, entire, Hungarian Wirehaired Vizsla presented with a three-month history of generalised scale and alopecia of the head and neck with severe pruritus and erythema of the ventral abdomen and feet.